Portfolio

 

Carmel's 'SMART' Drug Product Development Platform

Carmel Biosciences focuses on prescription drug products in large and growing markets, including obesity and lifestyle induced diseases. A primary driver of the Carmel Biosciences value proposition is in the field of reformulation of gold standard safety profile of drug products 505(b)(2). This results in the leveraging of their known safety and efficacy, thereby minimizing risk of failure.

Carmel Drug Discovery Program Focuses in the key areas of disease management for multiple indications

Maintains a strong global network to create a superior drug discovery organization

Maintains and fosters R&D alliances and partnerships with internationally renowned research institutes and experts

Operates successfully as a virtual company model with low overhead and optimized efficiencies

Carmel Drug Product Pipeline

CAR-501 FDA-Approved PREXXARTAN™ Valsartan Oral Solution

CAR-502 FDA Pre-IND Approved; currently in development

CAR-503 Pre-IND; currently in early stage

CAR-504 FDA Pre-IND Approved; currently in development

CAR-505 FDA Pre-IND Approved; currently in development

CAR-506 FDA Pre-IND Approved; currently in development

CAR-507 FDA Pre-IND Approved; currently in development